Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia.
Killander D, Dohlwitz A, Engstedt L, Franzén S, Gahrton G, Gullbring B, Holm G, Holmgren A, Höglund S, Killander A, Lockner D, Mellstedt H, Moe PJ, Palmblad J, Reizenstein P, Skårberg KO, Swedberg B, Udén AM, Wadman B, Wide L, Ahström L. Killander D, et al. Among authors: wadman b. Cancer. 1976 Jan;37(1):220-8. doi: 10.1002/1097-0142(197601)37:1<220::aid-cncr2820370132>3.0.co;2-w. Cancer. 1976. PMID: 1061636
Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary report.
Gahrton G, Björkholm M, Brenning G, Christenson I, Engstedt L, Franzén S, Gullbring B, Holm G, Högman C, Hörnsten P, Jameson S, Killander A, Simonsson-Lindemalm C, Lockner D, Lönnqvist B, Mellstedt H, Palmblad J, Paul C, Pauli C, Peterson C, Reizenstein P, Simonsson B, Skårberg KO, Udén AM, Wadman B. Gahrton G, et al. Among authors: wadman b. Cancer Chemother Pharmacol. 1979;2(1):73-6. doi: 10.1007/BF00253109. Cancer Chemother Pharmacol. 1979. PMID: 498423 Clinical Trial.
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia.
Udén AM, Brenning G, Engstedt L, Franzén S, Gahrton G, Gullbring B, Holm G, Höglund S, Jameson S, Killander A, Killander D, Lockner D, Mellstedt H, Palmblad J, Reizenstein P, Skårberg KO, Swedberg B, Wadman B, Wide L. Udén AM, et al. Among authors: wadman b. Scand J Haematol. 1975 Aug;15(1):72-80. doi: 10.1111/j.1600-0609.1975.tb01057.x. Scand J Haematol. 1975. PMID: 1058527 Clinical Trial.
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
Paul C, Björkholm M, Christenson I, Engstedt L, Gahrton G, Hast R, Holm G, Killander A, Lantz B, Lockner D, Lönnqvist B, Mellstedt H, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Udén AM, Wadman B, Oberg G. Paul C, et al. Among authors: wadman b. Cancer Chemother Pharmacol. 1981;6(1):65-73. doi: 10.1007/BF00253012. Cancer Chemother Pharmacol. 1981. PMID: 7023715 Clinical Trial.
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Lönnqvist B, Andersson B, Björkholm M, Engstedt L, Gahrton G, Hast R, Holm G, Killander A, Lantz B, Lockner D, Mellstedt H, Palmblad J, Paul C, Peterson C, Simonsson B, Stalfelt AM, Udén AM, Wadman B, Oberg G. Lönnqvist B, et al. Among authors: wadman b. Cancer Chemother Pharmacol. 1982;9(2):89-92. doi: 10.1007/BF00265385. Cancer Chemother Pharmacol. 1982. PMID: 7172410 Clinical Trial.
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K, Kimby E, Björkholm M, Mellstedt H, Engstedt L, Gahrton G, Johansson B, Killander D, Robérts KH, Stalfelt AM, Udén AM, Wadman B, Wählby S. Ideström K, et al. Among authors: wadman b. Eur J Cancer Clin Oncol. 1982 Nov;18(11):1117-23. doi: 10.1016/0277-5379(82)90092-x. Eur J Cancer Clin Oncol. 1982. PMID: 6897633 Clinical Trial.
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma.
Ahre A, Björkholm M, Mellstedt H, Holm G, Brenning G, Engstedt L, Gahrton G, Hällen J, Johansson B, Johansson SG, Karnström L, Killander A, Lerner R, Lockner D, Lönnqvist B, Simonsson B, Stalfelt AM, Ternstedt B, Wadman B. Ahre A, et al. Among authors: wadman b. Eur J Cancer Clin Oncol. 1983 Apr;19(4):499-506. doi: 10.1016/0277-5379(83)90113-x. Eur J Cancer Clin Oncol. 1983. PMID: 6345174 Clinical Trial.
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.
Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å. Paul C, et al. Among authors: wadman b. Leuk Lymphoma. 1991;3(5-6):355-64. doi: 10.3109/10428199109070279. Leuk Lymphoma. 1991. PMID: 27467426
Oxymetholone treatment in myelofibrosis.
Hast R, Engstedt L, Jameson S, Killander A, Lundh B, Reizenstein P, Skårberg KO, Udén AM, Wadman B. Hast R, et al. Among authors: wadman b. Blut. 1978 Jul 14;37(1):19-26. doi: 10.1007/BF01006549. Blut. 1978. PMID: 667366
48 results